EGA
VYNT

Eagle Global Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Eagle Global Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-148
Closed -$88K – 386
2017
Q2 		$88K Buy
+148
New +$86.5K ﹤0.01% 428
2016
Q4 		– Sell
-242
Closed -$63K – 417
2016
Q3 		$63K Sell
242
-320
-57% -$98K ﹤0.01% 351
2016
Q2 		$168K Buy
562
+230
+69% +$80.9K ﹤0.01% 332
2016
Q1 		$141K Buy
332
+134
+68% +$50.1K 0.01% 339
2015
Q4 		$98K Buy
+198
New +$143K ﹤0.01% 351

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Eagle Global Advisors's VYNT Position: Q3 2017 in Review

Eagle Global Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2017, closing a stake of 148 shares — an estimated $88K sold.

Eagle Global Advisors first reported a position in VYNT in Q4 2015 and held it in 5 quarters. The position peaked at $168K in Q2 2016. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2017.

  • Eagle Global Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 148 Vyant Bio, Inc. Common Stock shares in Q3 2017, an estimated $88K.
  • Eagle Global Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • Eagle Global Advisors's Vyant Bio, Inc. Common Stock position peaked at $168K in Q2 2016.
  • 26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.